Judge Trims Expert Testimony In Novartis Bone Drug Suit

Law360, New York (March 22, 2012, 6:15 PM EDT) -- A federal judge on Wednesday deemed a physician unqualified to opine on Novartis Pharmaceuticals Corp.'s interactions with regulators in a suit over its bone drugs, curbing the testimony of the doctor, known among defense lawyers as an omnipresent plaintiffs expert in product liability suits.

U.S. District Judge Graham C. Mullen ruled Suzanne Parisian, a physician and former U.S. Food and Drug Administration medical officer, could not testify on Novartis' conduct tied to approvals of its drugs Aredia and Zometa or on its interactions with the FDA...
To view the full article, register now.